Liza Vertinsky

Professor of Law

Office

447

Phone

(410) 706-7279

Photo of Liza Vertinsky

Education

  • Ph.D., Economics, Harvard University, 1998
    J.D., Magna Cum Laude, Harvard Law School, 1997
    M.A., Economics, University of British Columbia, 1992
    B.A., Honors, Oxford University, 1991

Liza Vertinsky is a professor of law at the University of Maryland Francis King Carey School of Law, where she teaches and researches topics at the intersection of law, economics and social justice. She is a nationally recognized expert on the regulation of healthcare markets and emerging technologies, the role of public private collaborations in innovation, and access to medicines.

Professor Vertinsky clerked for Judge Stanley Marcus, first for the U.S. District Court in the Southern District of Florida and then for the Eleventh Circuit Court of Appeals. She then practiced for a decade at two top law firms in the greater Boston entrepreneurial ecosystem, focusing on intellectual property transactions in the biomedical industry and university technology transfer. Professor Vertinsky joined the Emory Law School faculty in 2007, and the Maryland Carey Law faculty in July 2022. Her areas of expertise include the regulation of healthcare markets, the regulation of emerging technologies, AI and the law, global health law and policy, genetic privacy, intellectual property and innovation, and law and economics.

Books

A Law & Economics Approach to Criminal Gangs (1999).

Articles

The More Things Change: In Memory of Dmitry Karshtedt, 21 Northwestern Journal of Technology & Intellectual Property 299 (2024). Abstract

Pharmaceutical (Re)Capture, 20 Yale Journal of Health Policy Law & Ethics 146 (2022).

Righting a Reproductive Wrong: A Statutory Tort Solution to Misrepresentation by Reproductive Tissue Providers, 60 Houston Law Review 1 (2022) (with others). Abstract

An Institutional Solution to Build Trust in Pandemic Vaccines, 31 Harvard Public Health Review (2022), DOI:10.54111/0001/EE19 (with Yaniv Heled & Ana Santos Rutschman). Abstract

The Need for the Tort Law Necessity Defense in Intellectual Property Law, 2021 University of Chicago Legal Forum 127 (with Yaniv Heled & Ana Santos Rutschman).

A Wrong Without a Remedy: Leaving Parents and Children with a Hollow Victory in Lawsuits Against Unscrupulous Sperm Banks, 96 Chicago-Kent Law Review 115 (2021) (with Yaniv Heled and Timothy Lytton).

Public-Private Litigation for Health, 2021 Utah Law Review 1173 (with Reuben Guttman).

Genetic Paparazzi: Beyond Genetic Privacy, 82 Ohio State Law Journal 409 (2021) (with Yaniv Heled).

Regulatory Reactivity: FDA and the Response to COVID-19, 76 Food & Drug Law Journal 318 (2021) (with Yaniv Heled & Ana Santos Rutschman).

The Problem with Relying on Profit-Driven Models to Produce Pandemic Drugs, 7 Journal of Law & the Biosciences, no. 1, 2020, https://doi.org/10.1093/jlb/lsaa060 (with Yaniv Heled & Ana Santos Rutschman).

Why Healthcare Companies Should Be(come) Benefit Corporations, 60 Boston College Law Review 73 (2019) (with Yaniv Heled & Cass Brewer).

North-South Collaborations to Promote Health Innovation in Africa, 67 Emory Law Journal 619 (2018) (with Dennis C. Liotta, Solomon Nwaka & Stephen D. Sencer).

Hidden Costs of Free Patents, 78 Ohio State Law Journal 1379 (2017).

Boundary-Spanning Collaboration and the Limits of Joint Inventorship Doctrine, 55 Houston Law Review 401 (2017).

Pre-Competition, 95 North Carolina Law Review 67 (2016) (with Jorge L. Contreras).

Patents, Partnerships, and the Pre-Competitive Collaboration Myth in Pharmaceutical Innovation, 48 U.S. Davis Law Review 1509 (2015).

Making Room for Cooperative Innovation, 41 Florida State University Law Review 1067 (2014).

Making Knowledge and Making Drugs: Experimenting with University Innovation Capacity, 62 Emory Law Journal 741 (2013).

An Organizational Approach to the Design of Patent Law, 13 Minnesota Journal of Law, Science & Technology 211 (2012).

Universities as Guardians of Their Inventions, 2012 Utah Law Review 1949.

Comparing Alternative Institutional Paths to Patent Reform, 61 Alabama Law Review 501 (2010).

Reconsidering Patent Licensing in the Aftermath of Medimmune, 45 Houston Law Review 1609 (2009).

Responding to the Challenges of "Against Intellectual Monopoly", 5 Review of Law & Economics 1115 (2009).

Thinking About Thinking Machines: Implications of Machine Inventors for Patent Law, 8 Boston University Journal of Science & Technology 574 (2002) (with Todd M. Rice).